NCT01474460View on ClinicalTrials.gov

Use of Phytonadione to Reduce International Normalized Ratio (INR) Variability in Patients on Long-term Warfarin Therapy

NACompletedINTERVENTIONAL

Enrollment

370

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions

Coagulation Delay

Interventions

DIETARY_SUPPLEMENT

phytonadione

Phytonadione 200mcg PO daily for 6 months + normal dose of warfarin and standard of care treatment

Trial Locations (1)

33612

James A. Haley VA Hospital, Tampa

All Listed Sponsors

lead

James A. Haley Veterans Administration Hospital

FED

NCT01474460 - Use of Phytonadione to Reduce International Normalized Ratio (INR) Variability in Patients on Long-term Warfarin Therapy | Biotech Hunter | Biotech Hunter